A new light-based sensor detects cancer markers at near-zero concentrations.

There’s been talk about liquid biopsies and the promise of using blood samples to test for a wide variety of cancers at once.

Colorectal cancer is highly treatable when caught early—and FIT tests make screening easier than ever with a simple at‑home ...

Current trial data suggest that many MCED tests demonstrate high specificity, often above 99% thereby reducing the likelihood of false positives ...

The ad, which aired during the Super Bowl over the weekend, promoted a new product by Hims & Hers, a blood test designed to detect over 50 types of cancer before symptoms appear. This includes hard-to ...

A telehealth company that generated buzz last year with a defiant Super Bowl ad hawking weight-loss drugs is back for this year’s championship with a socially charged pitch around longevity. “Rich ...

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...

A growing body of research provides a better understanding of cancer’s causes, especially possible links to alcohol, food and behaviors. About 2.1 million people in the U.S. are expected to be ...

Cancer is appearing in Americans earlier than ever before. However, many younger people are missing out on their screenings, which can lead to later-stage diagnoses with worse outcomes. Blood-based ...

Cancer was hardest to defeat because it stayed invisible for too long. This breakthrough showed how tiny biological signals in the blood revealed cancer long before symptoms appeared. Using advanced ...